MHT Initiation May Reduce Cardiovascular Risk in Women With Vasomotor Symptoms
TUESDAY, Sept. 22, 2026-- Menopausal hormone therapy (MHT) initiation in perimenopausal or recently postmenopausal women with vasomotor symptoms may reduce cardiovascular disease (CVD) risk, with more pronounced benefits in women who initiated MHT...
Read more »